Skip to main content
Publications
Jedynak P, Bustamante M, Rolland M, Mustieles V, Thomsen C, Sakhi AK, Sabaredzovic A, Foraster M Prenatal exposure to synthetic phenols assessed in multiple urine samples and dysregulation of steroid hormone homeostasis in two European cohorts
Zubizarreta-Arruti U, Bosch R, Soler Artigas M, Cabana-Dominguez J, Llonga N, Carabi-Gassol P, Macias-Chimborazo V, Vilar-Ribo L, Ramos-Quiroga JA, Pagerols M, Prat R, Rivas C, Pagespetit E, Puigbo J, Espanol-Martin G, Raimbault B, Valentin A, Sunyer J, Foraster M Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren
Aguilar-Lacasana S, Cosin-Tomas M, Raimbault B, Gomez-Herrera L, Sanchez O, Zanini MJ, Capdevila RP, Foraster M Epigenome-wide association study of pregnancy exposure to green space and placental DNA methylation 10.1016/j.envres.2025.121286
Kovesdy CP, Ebert N, Vizcaya D, Walsh M, Kosiborod MN, Layton JB Ziemiecki R Johannes CB Change in urine albumin-creatinine ratio and occurrence of hyperkalemia in patients initiating finerenone in the United States: a cohort study from the FOUNTAIN platform
Johannes CB Ziemiecki R Layton JB Clinical profile and treatment adherence in patients with type 2 diabetes and chronic kidney disease who initiate an SGLT2 inhibitor: a multi-cohort study
Abellan A Expanding the OMOP common data model to support perinatal research in network studies
Ahn JH, da Silva Pedrosa M, Lopez LR Tibbs TN Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn's disease
Samuelsson K, Rivas I, Raimbault B, Dominguez A, Galmes T, Valentin A, Foraster M A comprehensive GPS-based analysis of activity spaces in early and late pregnancy using the ActMAP framework 10.1016/j.healthplace.2025.103413
Pistillo A, Warkentin S, Abellan A Residential relocation and changes in patterns of environmental exposures by health determinants among children and adolescents in Catalonia, Spain
Rao S Forns J MacKay R Anthony MS Layton B Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics
Dominguez A, Dadvand P, Cirach M, Arevalo G, Barril L, Foraster M Development of land use regression, dispersion, and hybrid models for prediction of outdoor air pollution exposure in Barcelona
Rao S Forns J MacKay R Anthony MS Layton B Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics
Knox B, Guil-Oumrait N, Basagana X, Cserbik D, Dadvand P, Foraster M Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth
Xie J, Lopez-Guell K, Dedman D, Duarte-Salles T, Kolde R, Lopez-Blasco R, Martinez A, Mercier G, Abellan A Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data
Rao S Forns J MacKay R Anthony MS Layton B Comparing the mortality risk of patients on FDA-approved treatment for Parkinson's disease psychosis, pimavanserin, vs other antipsychotics
Kovesdy CP, Layton JB Johannes CB Reduction in Urinary Albumin-to-Creatinine Ratio (UACR) in people with CKD and type 2 diabetes initiating finerenone: a CKD stage subgroup analysis from the FOUNTAIN platform
Kovesdy CP, Layton JB Johannes CB Reduction in Urinary Albumin-to-Creatinine Ratio (UACR) in people with CKD and type 2 diabetes initiating finerenone: a comedication subgroup analysis from the FOUNTAIN platform
Tonne C, Ranzani O, Alari A, Ballester J, Basagana X, Chaccour C, Dadvand P, Duarte T, Foraster M Air pollution in relation to COVID-19 morbidity and mortality: a large population-based cohort study in Catalonia, Spain (COVAIR-CAT)
Girardi A, Limoncella G, Hyeraci G, Roberto G, Bartolini C, Paoletti O, Messina D, Villalobos F, Bissacco C, Van den Burg J, Houben E, Santaca k, Lentile V, Ingrasciotta Y, Trifiro G, Hoxhaj V, Duran C, Riera-Arnau J, Garcia P, Martin-Perez M, Huerta-Alvarez C, Llorente-Garcia A, Sanchez-Saez F, Rodriguez-Bernal C, Lassalle R, Jove J, Bernard M, Thurin N, Jordan S, Thayer D, Evans H, Coldea A, Manfrini M, Van Gelder M, Hayati S, Schink T, Tari M, Pajouheshnia R Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model
Mayer SE, Kawai A Rao S Calingaert B Johannes CB Layton JB Gilsenan A Interim utilization results from a post-approval safety study of Pfizer-BioNTech monovalent COVID-19 vaccine in the United States
Danysh HE Gilsenan A Garcia de Albeniz Martinez X Bartsch J Calingaert B Layton JB Gutierrez L Validation of algorithms to identify breast cancer and bladder cancer among patients with type 2 diabetes mellitus in United States medicare administrative claims
Layton JB Bui CL Anthony MS Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
Layton JB Bui C Anthony MS Risk of cardiovascular adverse events after COVID-19 diagnosis in the United States
Domenech E, Fortuny J Martinez D Tormos A A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Ahmadizar F, Fortuny J Plana E Weinrib R Garcia Esteban R Boric K Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European healthcare data sources: methods and results of the second study feasibility assessment
Jacobson MH, Sabido M, Afonso AS, Ajao A, Alghamdi EA, Andrade S, Bennett D, Kharat V, Kurzinger ML, Le Noan-Laine M, Molgaard-Nielsen D, Murray G, Rivero-Ferrer E Algorithms to identify major congenital malformations in routinely collected healthcare databases: a systematic literature review
Peetluk LS, Djibo DA, Layton JB Anthony MS Considerations for negative control outcome analyses in vaccine effectiveness studies: post-hoc analyses from an adult vaccine effectiveness study conducted within the FDA BEST initiative
Broe A, Willis SK, Dareng E, Haviland M, van Gelder MMHJ, Nordeng HME, Wood ME, Sahin L, Margulis AV Rivero-Ferrer E Building global consensus on definitions for drug safety studies in pregnancy to improve harmonized evaluation of real-world data
Layton JB Bui CL Anthony MS Effectiveness over time of a complete primary series of the original, monovalent COVID-19 vaccines among adults aged 18-64 years in the United States
Layton JB Bui C Kawai AT Anthony MS Events on day zero of follow-up: considerations for cohort studies of adverse events after COVID-19 diagnosis
Johannes CB Ziemiecki R Layton JB Use of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease: a multicountry report from the FOUNTAIN platform
Pajouheshnia R Describing diversity of real-world data sources: a new framework adapted from the DIVERSE initiative scoping review
Weinrib R Fortuny J Martinez D Drug utilisation of radium-223 under routine clinical practice (DIRECT) in Europe: a post-authorisation safety study
